The 8 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 17.50, with a high estimate of 23.00 and a low estimate of 15.00. The median estimate represents a +144.07% increase from the last price of 7.17.
The current consensus among 8 polled investment analysts is to Buy stock in Avadel Pharmaceuticals PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.26
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.